Completed PHASE1 INTERVENTIONAL 3-arm
NCT07002229
A Clinical Study of the Interactions Between Azvudine Tablets (FNC) and Dolutegravir Sodium Tablets (DTG)
Sponsor: Henan Genuine Biotech Co., Ltd.
Conditions
Healthy
Updated 1 time since 2025 Last updated: May 23, 2025 Started: Dec 9, 2021 Primary completion: Feb 23, 2022 Completion: Sep 9, 2022
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
A PHASE1 clinical study on Healthy, this trial is completed. The trial is conducted by Henan Genuine Biotech Co., Ltd. and has accumulated 1 data snapshot since 2021. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
1 version recorded Completed — PHASE1
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Henan Genuine Biotech Co., Ltd.
Data source: Henan Genuine Biotech Co., Ltd.
For direct contact, visit the study record on ClinicalTrials.gov .